MX2018011767A - Composiciones que contienen ácidos tánicos y usos de las mismas. - Google Patents
Composiciones que contienen ácidos tánicos y usos de las mismas.Info
- Publication number
- MX2018011767A MX2018011767A MX2018011767A MX2018011767A MX2018011767A MX 2018011767 A MX2018011767 A MX 2018011767A MX 2018011767 A MX2018011767 A MX 2018011767A MX 2018011767 A MX2018011767 A MX 2018011767A MX 2018011767 A MX2018011767 A MX 2018011767A
- Authority
- MX
- Mexico
- Prior art keywords
- tannic acids
- compositions
- compositions containing
- containing tannic
- acids
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920002258 tannic acid Polymers 0.000 title abstract 3
- 235000015523 tannic acid Nutrition 0.000 title abstract 3
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
Abstract
Composiciones (por ejemplo, composiciones farmaceuticas, composiciones nutraceuticas o composiciones de alimento medicinal) que comprenden acidos tanicos, particularmente acidos tanicos que tienen mas de tres porciones de galoilo, metodos de preparación de los mismos y usos de los mismos para el tratamiento de la obesidad, hiperlipidemia, diabetes o trastornos del sistema nervioso central.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662313946P | 2016-03-28 | 2016-03-28 | |
US201762458216P | 2017-02-13 | 2017-02-13 | |
PCT/CN2017/078361 WO2017167168A1 (en) | 2016-03-28 | 2017-03-28 | Compositions containing tannic acids and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018011767A true MX2018011767A (es) | 2019-03-28 |
Family
ID=59963410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018011767A MX2018011767A (es) | 2016-03-28 | 2017-03-28 | Composiciones que contienen ácidos tánicos y usos de las mismas. |
Country Status (11)
Country | Link |
---|---|
US (4) | US10105378B2 (es) |
EP (1) | EP3436040A4 (es) |
JP (2) | JP7066627B2 (es) |
KR (1) | KR102476644B1 (es) |
CN (1) | CN108348557A (es) |
CA (1) | CA3018893A1 (es) |
HK (1) | HK1256040A1 (es) |
IL (1) | IL261887B2 (es) |
MX (1) | MX2018011767A (es) |
RU (1) | RU2715703C1 (es) |
WO (1) | WO2017167168A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018011767A (es) | 2016-03-28 | 2019-03-28 | Syneurx Int Taiwan Corp | Composiciones que contienen ácidos tánicos y usos de las mismas. |
KR20200097255A (ko) * | 2017-12-07 | 2020-08-18 | 신유알엑스 인터내셔널 (타이완) 코포레이션 | 탄닌산 조성물을 제조하기 위한 개선된 풍부화 방법 |
US10927138B2 (en) * | 2018-05-29 | 2021-02-23 | Syneurx International (Taiwan) Corp. | Inhibitors of D-amino acid oxidase (DAAO) and uses thereof |
CN109200272B (zh) * | 2018-09-12 | 2021-11-26 | 中山大学 | 一种口服艾塞那肽纳米颗粒制剂及其制备方法和应用 |
KR102246444B1 (ko) | 2018-12-18 | 2021-04-29 | 김상희 | 오배자 추출물 및 프락신을 유효성분으로 포함하는 인지력 개선 및 치매 예방 또는 치료용 조성물 |
US11154531B2 (en) | 2020-02-08 | 2021-10-26 | Syneurx International (Taiwan) Corp. | Compounds and pharmaceutical uses thereof |
TWI803858B (zh) | 2020-04-23 | 2023-06-01 | 心悅生醫股份有限公司 | 化合物及其醫藥用途 |
KR20230006896A (ko) * | 2020-05-05 | 2023-01-11 | 신유알엑스 인터내셔널 (타이완) 코포레이션 | 뉴로수티칼의 염 및 이의 용도 |
KR102224178B1 (ko) * | 2020-07-24 | 2021-03-08 | 재단법인 전남바이오산업진흥원 | 붉가시나무(Quercus acuta Thunb.) 열매 또는 잎 추출물을 포함하는 인지능력 또는 기억력개선용 조성물 |
CN112353795A (zh) * | 2020-12-14 | 2021-02-12 | 中山万汉制药有限公司 | 奥利司他及其组合物的抗疟疾用途 |
KR20230060470A (ko) | 2021-10-25 | 2023-05-04 | 서울대학교산학협력단 | 신규한 락토바실러스 플란타럼 d2-3 균주 및 이의 용도 |
WO2024022411A1 (en) * | 2022-07-26 | 2024-02-01 | Syneurx International (Taiwan) Corp. | Compounds and compositions for treating influenza |
CN116115731A (zh) * | 2023-01-20 | 2023-05-16 | 安徽泰格生物科技有限公司 | 一种降血糖的组合物、制剂及其应用 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
JPH0751507B2 (ja) * | 1988-02-23 | 1995-06-05 | 株式会社日本ハイポックス | タンニン酸の渋味及び苦味低減方法 |
US5211657A (en) | 1988-11-07 | 1993-05-18 | The United States Government As Represented By The Secretary Of The Department Of Health And Human Services | Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5571551A (en) | 1993-05-27 | 1996-11-05 | Kraft Foods, Inc. | High molecular weight gallotannins as a stain-inhibiting agent for food dyes |
DE69819593T2 (de) | 1997-05-09 | 2004-09-16 | Rohm And Haas Co. | Detergensformulierungen |
KR20000019718A (ko) | 1998-09-15 | 2000-04-15 | 박호군 | 탄닌 또는 탄닌 유래 페놀성 화합물을 포함하는 동맥경화증, 고지혈증 및 간질환의 예방 및 치료용 조성물 |
EP1158997A2 (en) | 1999-03-09 | 2001-12-05 | University Of Southern California | Method of promoting myocyte proliferation and myocardial tissue repair |
CN1276926C (zh) | 2002-09-10 | 2006-09-27 | 北京富邦博尔生物科技有限公司 | 一种单宁酸的纯化方法 |
CN1193763C (zh) * | 2003-04-10 | 2005-03-23 | 四川倍达尔新技术开发有限公司 | 红景天总鞣质提取物及其在制备治疗老年性痴呆病药物中的应用 |
CN1313475C (zh) * | 2003-04-22 | 2007-05-02 | 上海大学 | 虎杖提取物虎杖鞣酸在制备降血糖、治疗糖尿病药物中的应用 |
CN1560077A (zh) | 2004-03-05 | 2005-01-05 | 山东大学 | 一种环丙沙星免疫原及其制备方法 |
US20090118202A1 (en) | 2007-10-31 | 2009-05-07 | Texas Tech University | Compositions and methods of treating hypertension with tannin complexes |
KR20090084159A (ko) * | 2008-01-31 | 2009-08-05 | 경북대학교 산학협력단 | 감 추출물 또는 탄닌을 유효성분으로 함유하는면역관련질환 치료용 조성물 |
JP2012508740A (ja) * | 2008-11-14 | 2012-04-12 | パーキンソンズ インスティテュート | 変性α−シヌクレイン機能の治療のための組成物および方法 |
CN101618066B (zh) * | 2009-08-04 | 2011-09-28 | 天津科技大学 | 核桃青皮总单宁的制备及其应用 |
WO2011149835A1 (en) * | 2010-05-24 | 2011-12-01 | Max International, Llc | Compositions and beverages comprising nutrients, vitamins, sugars, cysteine, and/or sugar-cysteine products |
JP2012116791A (ja) | 2010-12-01 | 2012-06-21 | Kao Corp | オートインデューサー−2阻害剤 |
CN102127125B (zh) | 2011-01-05 | 2015-10-14 | 中国林业科学研究院林产化学工业研究所 | 系列精制单宁酸多元组合化纯化制备工艺及其产品的组合化制备 |
CN102180917A (zh) * | 2011-03-20 | 2011-09-14 | 竹山林产化工实业有限公司 | 一种药用单宁酸的制备方法 |
CN102250159A (zh) * | 2011-04-28 | 2011-11-23 | 贵阳单宁科技有限公司 | 从含单宁的植物原料中提取和制备高纯度单宁酸的方法 |
CN102743419A (zh) * | 2012-05-31 | 2012-10-24 | 兰州理工大学 | 路路通总鞣质提取物的制备方法及其用途 |
MX2018011767A (es) | 2016-03-28 | 2019-03-28 | Syneurx Int Taiwan Corp | Composiciones que contienen ácidos tánicos y usos de las mismas. |
-
2017
- 2017-03-28 MX MX2018011767A patent/MX2018011767A/es unknown
- 2017-03-28 KR KR1020187031083A patent/KR102476644B1/ko active IP Right Grant
- 2017-03-28 EP EP17773198.1A patent/EP3436040A4/en active Pending
- 2017-03-28 RU RU2018137805A patent/RU2715703C1/ru active
- 2017-03-28 JP JP2018551820A patent/JP7066627B2/ja active Active
- 2017-03-28 WO PCT/CN2017/078361 patent/WO2017167168A1/en active Application Filing
- 2017-03-28 CA CA3018893A patent/CA3018893A1/en active Pending
- 2017-03-28 CN CN201780003658.XA patent/CN108348557A/zh active Pending
- 2017-12-07 US US15/834,387 patent/US10105378B2/en active Active
- 2017-12-07 US US15/834,428 patent/US10265336B2/en active Active
-
2018
- 2018-09-20 IL IL261887A patent/IL261887B2/en unknown
- 2018-11-26 HK HK18115092.5A patent/HK1256040A1/zh unknown
-
2019
- 2019-03-11 US US16/298,804 patent/US20190201427A1/en not_active Abandoned
-
2020
- 2020-05-26 US US16/883,815 patent/US11202791B2/en active Active
-
2022
- 2022-02-21 JP JP2022024942A patent/JP2022075675A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20190201427A1 (en) | 2019-07-04 |
JP2022075675A (ja) | 2022-05-18 |
IL261887B1 (en) | 2023-04-01 |
US10265336B2 (en) | 2019-04-23 |
EP3436040A1 (en) | 2019-02-06 |
CA3018893A1 (en) | 2017-10-05 |
JP7066627B2 (ja) | 2022-05-13 |
HK1256040A1 (zh) | 2019-09-13 |
US20180092935A1 (en) | 2018-04-05 |
US20180133237A1 (en) | 2018-05-17 |
CN108348557A (zh) | 2018-07-31 |
US11202791B2 (en) | 2021-12-21 |
JP2019515891A (ja) | 2019-06-13 |
US10105378B2 (en) | 2018-10-23 |
IL261887A (en) | 2018-10-31 |
EP3436040A4 (en) | 2019-12-11 |
WO2017167168A1 (en) | 2017-10-05 |
IL261887B2 (en) | 2023-08-01 |
KR102476644B1 (ko) | 2022-12-09 |
RU2715703C1 (ru) | 2020-03-03 |
US20200390791A1 (en) | 2020-12-17 |
KR20190005157A (ko) | 2019-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018011767A (es) | Composiciones que contienen ácidos tánicos y usos de las mismas. | |
PH12015501806B1 (en) | Novel benzopyran kinase modulators | |
EA033163B1 (ru) | Ингибиторы глутаминазы | |
MY168757A (en) | Novel compounds as modulators of protein kinases | |
MX2019000588A (es) | Moduladores de la somatostatina y usos de los mismos. | |
PH12016501724A1 (en) | Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | |
PH12017500571A1 (en) | Mono-or di-substituted indole derivatives as dengue viral replication inhibitors | |
NZ757081A (en) | Somatostatin modulators and uses thereof | |
MX2016013029A (es) | Compuestos de indanona sustituidos como modulares de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados. | |
MX2012006206A (es) | Preparaciones combinacion comprendiendo exosomas y corticosteroide. | |
MX2020005934A (es) | Metodos de enriquecimiento mejorado para preparar composiciones de acido tanico. | |
EP3572095A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HTLV-1 ASSOCIATED MYELOPATHIA | |
NZ728401A (en) | High purity oritavancin and method of producing same | |
BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
EP4311575A3 (en) | Methotrexate for proliferative vitreoretinopathy | |
EA201491426A1 (ru) | Новые фармацевтические композиции, содержащие фосфатидилсерин и куркумин | |
TW201713686A (en) | Methods for preparing modified von Willebrand factor | |
TN2018000122A1 (en) | Oxadiazaspiro compounds for the treatment of drug abuse and addiction | |
PH12020550050A1 (en) | Novel acylated insulin analogues and uses thereof | |
MX2016013588A (es) | Complejo de tanato de sitagliptina. | |
WO2016073493A3 (en) | Antifibrinolytic compounds | |
TW201613952A (en) | Cdca1-derived peptide and vaccine containing same | |
MX2019002647A (es) | Composiciones de tesofensina. | |
MX2021015026A (es) | Peptido derivado de urlc10 y vacuna que lo contiene. | |
EP2924024A3 (en) | Solid forms of lorcaserin hydrochloride |